GeneralBearishCrypto Briefing · Jun 276/10
📰
Swiss pharma faces potential US trade investigation as Washington turns up pressure on drug pricing
The US is considering a trade investigation into Swiss pharmaceutical companies over drug pricing practices, potentially disrupting exports and reshaping global pharmaceutical trade dynamics. This escalation reflects Washington's intensified focus on controlling drug costs domestically while pressuring major pharmaceutical exporters.
